Crohn’s disease is a type of disease in which inflammation of bowel occurs that affect any part of the gastrointestinal tract. The most common signs and symptoms are abdominal pain, weight loss, diarrhea and fever. Other complications can occur outside the gastrointestinal tract which includes inflammation of the eye, anemia, arthritis, skin rashes, and feeling tired. The skin rashes occur due to infections as well as erythematic nodosum or pyoderma gangrenosum. Bowel obstruction also happens very commonly and bowel cancer risk is more likely on the people who have the Crohn’s disease.

Crohn’s disease patient may experience Pain in the abdomen; rectum, joints or lower abdomen, and the Pain can be severe or mild and the Gastrointestinal can cause blood in stool, bloating, bowel obstruction, diarrhea, flatulence, nausea, or vomiting; the abdominal causes tenderness and cramping and the whole body suffers from fever, fatigue and loss of appetite and the most common things in this disease are mouth ulcer, skin rash, slow growth, weight loss, anal fissure, arthritis, depression and acute episodes.



Facts of ENTYVIO (vedolizumab) 300mg Injection ?

  • Medicine Name: ENTYVIO
  • Generic Name: vedolizumab
  • Approval Date: May 20, 2014
  • Company Name: Takeda Pharmaceutical Company Limited

Available as (Form & Strength): 300 mg Injection for Intravenous use